2.04.91 General Approach to Genetic Testing

For panel testing, see Blue Shield of. California Medical Policy: General Approach to Evaluating the Utility of Genetic Panels. Genetics ...

MP 2.04.91 - General Approach to Genetic Testing

Customer service may assist with answers to general questions regarding medical policy, benefits, claims or prior authorization.

General Approach to Genetic Testing - Blue Cross of Idaho

Diagnostic. Page 4. Original Policy Date: May 2013. Page: 4. MP 2.04.91. General Approach to Genetic Testing b. Prognostic c. Therapeutic. 3.

Genetic Testing: General Approach to Genetic and Molecular Testing

Targeted carrier screening is defined as a test that screens for a known mutation in one gene associated with a specific genetic condition. IV.

General Approach to Genetic Testing - Capital Blue Cross

Blue Cross Blue Shield Association Medical Policy Reference Manual. 2.04.91, Genetic. Approach to Genetic Testing. December 2017. X. POLICY ...

12.04.91 General Approach to Genetic Testing

2.04.91. Policy. [TOP]. Genetic testing classified in one of the categories below may be considered medically necessary when all criteria are ...

FEP 2.04.121 Miscellaneous Genetic and Molecular Diagnostic Tests

2.04.91 - General Approach to Genetic Testing. 2.04.92 - General Approach to Evaluating the Utility of Genetic Panels. Miscellaneous Genetic and Molecular ...

General Approach to Genetic and Molecular Testing - Health Net

An association with the gene or multigene panel and disease has been established. Page 6. Concert Genetics Genetic Testing: General Approach to ...

FEP Medical Policy Manual - FEPBlue

Please see Section 6 General exclusions. Benefits are available for specialized diagnostic genetic testing when it is medically necessary to ...

MEDICAL POLICY - GENETIC TESTING AND COUNSELING

Blue Cross Blue Shield Association. General approach to genetic testing. Medical Policy. Reference Manual. 2.04.91. Published February 2013.

Underutilization of BRCA1/2 testing to guide breast cancer treatment

Women with early-onset (age ≤40) breast cancer are at high risk of carrying deleterious mutations in the BRCA1/2 genes; genetic assessment is thus ...

Germline Genetic Testing for Hereditary Breast Ovarian Cancer ...

MP 2.326 General Approach to Genetic Testing. MP 2.384 Germline Genetic Testing for Hereditary Diffuse Gastric Cancer (CDH1,. CTNNA1). MP 5.013 ...

GERMLINE GENETIC TESTING FOR BRCA1, BRCA2, AND PALB2 ...

BRCA and BART testing as a screening test for cancer in women in the general population. • BRCA and BART testing for unaffected individuals of ...

Genetics of Breast and Gynecologic Cancers (PDQ®) - NCI

In general, multigene panel testing increases the yield of non ... Risk factor analysis and implications for genetic testing. JAMA 278 ...

Germline and Somatic Biomarker Testing (Including Liquid Biopsy ...

Germline variants in the BRCA1 and BRCA2 genes are responsible for the cancer susceptibility in most HBOC families, especially if ovarian cancer ...

BRCA1 and BRCA2 (PDQ®) - National Cancer Institute

Addressed in general terms and other guidelines referenced. Genetic Counseling: Addressed. References. U.S. Preventive Services Task Force: ...

Interest in Cancer Predisposition Testing and Carrier Screening ...

Prior research examining interest in genetic testing has not generally examined the context of population-based approaches offered in routine healthcare or ...

2.04.02 Genetic Testing for BRCA1 or BRCA2 for Hereditary Breast ...

prevalence of BRCA variants compared with the general population of patients with pancreatic adenocarcinoma. Table 2. BRCA Variant Rates in ...

Genetic Testing for Breast, Ovarian, Pancreatic and Prostate ...

For all other purposes, including, but not limited to, testing of the general population, genetic testing ... one, a population-screening approach ...

Genetic Cancer Susceptibility Panels Using Next Generation ...

▫ General Approach to Evaluating the Utility of Genetic ... General genetic cancer susceptibility panel testing is considered experimental /.